Leading science, pioneering therapies

Edinburgh BioQuarter

Edinburgh Bioquarter is an academic medical centre with a focus on interdisciplinary research and translational medicine.


The campus brings together clinicians, industrialists, patients, scientists, state-of-the-art pre-clinical and clinical research facilities, and an academic teaching hospital on one campus.

Extending to more than 100 acres, Edinburgh Bioquarter is a £600m joint venture between Scottish Enterprise, the University of Edinburgh and NHS Lothian.

Once fully developed, the BioQuarter will offer up to 1.4m sq ft (130,063 sq m) of specialist accommodation for academic, commercial and healthcare activity.

The BioQuarter links a broad range of leading companies and research institutions, providing world class facilities with one-stop access to its unique combination of pre-clinical and clinical excellence. The site currently boasts over 1,300 researchers, 120 academic clinicians, 960 inpatient beds, 15 on-site companies, an MHRA accredited Phase I clinical trials suite, a clinical research imaging centre housing CT/MRI/PET scanners, a GMP cell therapy manufacturing facility and an NHS clinical service laboratory.

Future plans for the site include the construction of the Edinburgh Sick Children’s Hospital, which will provide an additional 600 patient beds and a paediatric clinical trials suite, and the Department of Clinical Neurosciences, both scheduled to open in 2018/2019. Plans are also being taken forward for further university research institutes, a second multi-occupancy building for companies wishing to locate on the site as well as on site hotel and conferencing facilities.